Reviewer #2 (Public review): Blocking SHP2 benefits FGFR2 inhibitor and overcomes its resistance in FGFR2-amplified gastric cancer

Read full text Summarise with VIRAT
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Protein Tyrosine Phosphatases Fibroblast Growth Factor Research Gastric Cancer Management and Outcomes

Publication details

Journal / source
eLife
Publication date
23 March 2026
Language
EN